The clinical relevance of chemosensitivity testing in ovarian cancer

Cancer Detection and Prevention

Volumn 22, Issue 4, 1998, Pages 305-312

  Taylor, C G ^a   Sargent, J M ^a   Elgie, A W ^a   Reid, F D A ^a   Alton, P A ^a   Hill, J G ^a  

^a Pembury Hospital   (United Kingdom)

Author keywords

Chemosensitivity testing; Drug resistance; Ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ADENOCARCINOMA; ARTICLE; CELL CULTURE; DRUG EFFECT; DRUG RESISTANCE; FEMALE; HUMAN; MORTALITY; OVARY TUMOR; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; OVARIAN NEOPLASMS; SENSITIVITY AND SPECIFICITY; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0031805773     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1500.1998.CDOA39.x     Document Type: Article

References (21)